Position in ARGX
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$2,921
-$442 QoQ
Shares Held
4
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Plante Moran Financial Advisors, LLC holds $461,659 across 15 Biotechnology names. ARGX ranks #8 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
635 | $210,102 | |
| 2 | RLAY |
Relay Therapeutics, Inc.
|
10,836 | $107,818 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
169 | $75,465 | |
| 4 | EVMN |
Evommune, Inc.
|
1,147 | $26,369 | |
| 5 | SABS |
SAB Biotherapeutics, Inc.
|
5,925 | $22,692 | |
| 6 | OMER |
Omeros Corp
|
1,000 | $10,560 | |
| 7 | BHVN |
Biohaven Ltd.
|
362 | $3,062 | |
| 8 | ARGX |
Argenx SE
This page
|
4 | $2,921 |
All Filings in ARGX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,921 | 4 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $3,363 | 4 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $2,950 | 4 | Shares | Sole | 2025-11-05 | |
| No filing history on record for this holder in this stock. | ||||||